To me Resapp expected FDA by now. Hasn't come so no money left to commercialise. Very few timelines have been met - although the daily posters on here responsible for some false expectations.
The delays are costing long term shareholders $s. Nothing much to do except wait wait wait or sell.
RAP Price at posting:
24.0¢ Sentiment: Hold Disclosure: Held